What are the opening hours?

Monday 8am - 5pm Tuesday 8am - 5pm Wednesday 8am - 5pm Thursday 8am - 5pm Friday 8am - 12pm

Biocytics

The Applications of Living Cells. Biotech comoany incubated within Carolina BioOncology Institute. https://www.facebook.com/share/1AvKAi3VJg/?mibextid=wwXIfr

Our mission is to research and develop novel cellular therapies.

11/21/2025

Biocytics Inc announces the successful completion of a productive FDA INTERACT meeting supporting our plans to manufacture autologous immune cell therapies at the point of care.

This initial regulatory engagement validates the scientific promise of our immuno-oncology platform and our lead investigational fraction, BioCytics Immune Fraction #1 (BCyIF-1). The FDA’s feedback reinforces our continued progress toward an IND submission and first-in-human clinical trials targeted for 2027, advancing our mission to bring innovative cell therapies to patients with solid tumors.

Learn more at www.biocytics.com or read the full announcement at PR Newswire at www.bit.ly/4ibp5of.

11/15/2025

Big thank you to the students from Davidson College for visiting! We loved sharing our work, our mission, and the exciting career paths ahead in biotech and in immuno-oncology cancer research.

11/12/2025

Today we welcomed to BioCytics Inc for an exciting presentation on Revolutionizing Immune Cell Therapy with Functional Single Cell Analysis.

We continue to explore advanced technologies that accelerate discovery and deepen our understanding of immune cell function to strengthen our cell therapy development pipeline.

11/07/2025

We are proud to celebrate Dr. Gaby Lizana-Vasquez, BioCytics HAL Research Scientist, for being selected as a 2025 International Society for Cell & Gene Therapy Cell Therapy Leadership Training Program Scholar. 🧬

This recognition reflects our mission at BioCytics to advance cell therapies through innovation, collaboration, and scientific excellence.

We are honored to see Dr. Lizana-Vasquez representing our team among the next generation of leaders shaping the future of cellular medicine. 🌍

09/15/2025

Biocytics and Carolina BioOncology Institute are proud to sponsor the Biomedical Sciences Symposium hosted by UNC Charlotte’s Center for Biomedical Engineering and Science in collaboration with the North Carolina Biotechnology Center.

This event unites breakthrough discoveries, translational research, and new collaborations in biomedical sciences. We are honored to support a forum that further advances science, fosters partnerships, and shapes the future of biomedical research!🔬

09/07/2025

✨ Congratulations to Dr. John Powderly and the entire team at Carolina BioOncology Institute on 20 years of advancing cancer care and research! ✨

Founded by Dr. John Powderly in 2005, CBOI began with a vision to provide patients with access to the latest Phase I immuno-oncology clinical trials. From humble beginnings of decision making around a kitchen table, the institute has grown into a nationally recognized center offering cutting-edge treatments for late-stage cancer patients.

Over the past two decades, CBOI has opened more than 150 early-phase immunotherapy trials and has become a beacon of hope for patients seeking innovative treatment options.

Here's to 20 years of dedication, innovation, and compassionate care and to many more! 👏💙

09/06/2025

🔬 Celebrating 20 years of innovation at BioCytics!

BioCytics began in 2005 as a true partnership between Dr. John Powderly and his brother Jim Powderly. Around their kitchen table that summer, they mapped out the vision for what would become a pioneering biotechnology company dedicated to individualized cell therapies, including development of an autologous adaptive immune cell therapy.

Based in Huntersville, North Carolina, BioCytics focuses on developing personalized cancer immunotherapies and continues to push the boundaries of pre-clinical research with the goal of transforming cancer treatment and offering hope to patients worldwide.

Here’s to two decades of collaboration, innovation, and vision, and many more to come! 🌟

07/25/2025

Big moves at Biocytics! ✨We’re thrilled to welcome Stephanie, William, Roberto, and Cheyenne, four amazing new team members joining us from leading biotech and life sciences companies. They bring serious experience in operations, quality, and GMP to help us grow our biobank and manufacturing space the right way.
The future is bright and we’re just getting started. 🚀🔬

07/18/2025

Carolina BioOncology Institute and Biocytics have successfully deployed the first live openEHR development framework in a US clinical setting. Announced today during the openEHR International Affiliate Program board meeting, this milestone lays the foundation for structured, interoperable, and regulatory-ready clinical data management.

The initial phase includes the deployment of the core framework and clinical datastore. 🔮Future phases will migrate the structured medical record data into the openEHR environment. The goal is to build a modern, scalable clinical infrastructure that empowers our clinical teams and research partners. Our focus is to accelerate the "citizen centric" democratization of clinical data while maintaining the highest standards of data integrity.

Find us on the global map at openEHR and reach out about new affiliate membership groups openEHR US & Global Life Science. Any questions, contact us directly for more information.

06/17/2025

We're thrilled to be supporting a cutting-edge research project led by Dr. Susan Trammell at UNC Charlotte, recently funded by NCInnovation!

In May, BioCytics joined as a sub-awardee to assist in the project’s evaluation of Light-Assisted Drying (LAD), a novel laser technology designed to enable ambient storage of vaccines and other therapeutics, potentially cutting refrigeration costs by up to 80%.

We’re honored to contribute to this impactful work that could help transform biologics storage and distribution.

🔗 Read more about the full award here: https://inside.charlotte.edu/2025/05/16/pinku-mukherjee-susan-trammell-awarded-ncinnovation-research-grants/ and about the other awardees here:
https://ncinnovation.org/media/ncinnovation-approves-13-6-million-to-support-17-university-rd-projects/

05/29/2025

🔬 Let us re-introduce ourselves — Welcome to BioCytics!

We’re a cell therapy company driven by one mission: to create personalized, autologous immune therapies for cancer patients using their body’s own adaptive immune response. At BioCytics, we believe the future of immunotherapy is already inside you.

Unlike traditional therapies, our AACT (Autologous Adaptive Cell Therapy) platform identifies and amplifies your body’s best immune cells—those already reacting to your tumor. Then we reinfuse them to help your immune system fight harder and smarter.

Follow us to learn more about our science, our team, and our mission.

04/25/2025

🔬🎉 As Lab Week comes to a close, we’re reflecting on the dedication, collaboration, and innovation that power everything we do at Biocytics. From breakthrough discoveries to daily wins behind the scenes, our lab team is the heart of it all.

Thank you to our incredible staff for your tireless commitment to science, precision, and progress. Every data point, every test, every challenge met—it all adds up to something bigger, and we're proud to do it together.

Here’s to continued excellence, curiosity, and impact. 💪✨

Address

9801 Kincey Avenue, Suite 145
Huntersville, NC
28078

Opening Hours

Monday	8am - 5pm
Tuesday	8am - 5pm
Wednesday	8am - 5pm
Thursday	8am - 5pm
Friday	8am - 12pm

Website

http://www.biocytics.com/

Alerts

Be the first to know and let us send you an email when Biocytics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Biocytics:

Shortcuts

Want your practice to be the top-listed Clinic in Huntersville?